The aim of the Clinical Research Support Centre is the development of medical research in the Podlaskie Voivodeship, which will allow for the management of the gap in the clinical research system and the implementation of ambitious, innovative scientific projects. It will provide comprehensive assistance to the university and its hospitals in the implementation of clinical trials. Cooperation with primary health care units and other clinical partners will complement the newly created regional research network.
The project of the Medical University of Bialystok for the implementation of the Centre was financed in the amount of PLN 10 million from the funds of the Medical Research Agency. As the president of the Medical Research Agency, dr hab. Radosław Sierpiński "The development of innovative medicine is a celebration of patients. Clinical trials determine the quality of medicine, allow access to therapy, and are often a life chance for patients”.
Rector of the Medical University of Bialystok, prof. Adam Krętowski, when opening the Clinical Research Support Centre, pointed out that modern research conducted at the center will contribute to a better quality of treatment of patients.
About 170 trials will be conducted annually at the Clinical Research Support Centre. So far, the university has raised PLN 100 million for various research projects.
Clinical Research Support Centre of the Medical University of Bialystok is currently implementing over a dozen projects financed by Medical Research Agency. They concern cardiology, oncology and reproduction. In 2010-2019, MUB units conducted nearly 400 clinical trials, of which 386 were commercial trials and 6 non-commercial ones. The University is also a sponsor of non-commercial, multicentre clinical trials (cardiology and oncology). The creation of the Clinical Research Support Centre will contribute to increasing the number and extension of the range of clinical trials carried out in MUB university hospitals, both commercial and non-commercial. Thanks to its dynamic operation, the Centre has a chance to attract commercial and non-commercial research that has not been available to the region's inhabitants so far, which will significantly contribute to the improvement of citizens' health.
